Sign in to view content

Safety of Intravitreal Pegcetacoplan for Geographic Atrophy: 12-Month Results of the OAKS and DERBY Trials

Caroline Baumal, MD, FASRS

Video
Published 2022

Related

Results From Part 1 of the Phase 2/3 SIGLEC Trial Assessing AVD-104 for Geographic Atrophy: Glyco-immunologic Modulation of Macrophage Activity
Rishi P. Singh, MD
Annual Meeting Talks
2024
Pegcetacoplan Safety: Panel Recap
Andre J. Witkin, MD
Updates from the Field
2024
Inhibition of Complement C3 in GA with NGM621: Phase 1 Study Results
David A. Eichenbaum, MD, FASRS
Updates from the Field
2021

Category: AMD-Non-Neovascular

See more